Furthermore, the results show that DSS promotes TAF9-mediated increases in fatty acid β-oxidation and decreases in LD accumulation during NAFLD, probably through an HDAC1-dependent mechanism. The gene discussed is TAF9; the disease is metabolic dysfunction-associated steatotic liver disease.